Home / Insights / Clinical Trial Monitoring in South Africa: What Sponsors Need to Know
Clinical Trials in South Africa
Clinical Trial Monitoring in South Africa: What Sponsors Need to Know
Clinical trial monitoring in South Africa is still monitoring: participant protection, protocol compliance, source data, investigational product, and a record that someone qualified looked. The setting changes the way that work has to be planned.
Sites differ sharply in staffing, pharmacy practice, source systems and the distance between the investigator and the coordinator who actually runs the visit. A plan copied from a European study, with the same visit frequency and the same expectations of same-week report turnaround, often fails quietly. The visits happen. The insight does not.
What sponsors should ask
Ask who is monitoring, how soon a report is reviewed by someone who can act, and what happens when a site misses a recruitment or data threshold. Ask whether remote review is a supplement or a substitute, and for which data. Ask how findings move from the monitor to clinical trial management and, if the work is outsourced, into sponsor oversight.
Clinical monitoring that stops at a completed checklist will not show you a site that is struggling. The useful visit is the one that names the issue, the owner, and the date by which it should have moved.
Sponsors comparing the local environment can also read clinical trial services in South Africa.